Evidence map›Paper›PMID 20032253›Full record

ArticleJournal of clinical microbiology2010

Molecular characterization of extended-spectrum cephalosporinase-producing Salmonella enterica serovar Choleraesuis isolates from patients in Thailand and Denmark.

Pantip Sirichote, Henrik Hasman, Chaiwat Pulsrikarn, Henrik Carl Schønheyder, Jurgita Samulioniené, Srirat Pornruangmong, Aroon Bangtrakulnonth, Frank M Aarestrup, Rene S Hendriksen

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 49 citations in OpenAlex.

  1. Guess Who's Back: Persistence and Circulation ofFoods (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Carriage of distinct blaBMC genomics · 2022
    Article
  4. Article
  5. What WGS Reveals aboutMicroorganisms · 2021
    Article
  6. Article
  7. Article
  8. Emergence ofFrontiers in microbiology · 2021
    Article
  9. Spread of Antimicrobial Resistance byAntibiotics (Basel, Switzerland) · 2020
    Article
  10. Co-Occurrence ofInfection and drug resistance · 2020
    Article
  11. Article
  12. Identification of a Novel Plasmid CarryingAntimicrobial agents and chemotherapy · 2019
    Article
  13. Cross-Border Transmission ofFrontiers in microbiology · 2019
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Systemic and extraintestinal forms of human infection due to non-typhoid salmonellae in Bulgaria, 2005-2010.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Pantip SirichoteRegional Medical Sciences Center Samutsongkhram, Department of Medical Sciences, Ministry of Public Health, Samutsongkhram, Thailand.
Henrik Hasman
Chaiwat Pulsrikarn
Henrik Carl Schønheyder
Jurgita Samulioniené
Srirat Pornruangmong
Aroon Bangtrakulnonth
Frank M Aarestrup
Rene S Hendriksen
Ministry of Public Health · THTechnical University of Denmark · DKAalborg University Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study was to characterize extended-spectrum cephalosporinase (ESC)-producing isolates of Salmonella enterica serovar Choleraesuis recovered from patients in Thailand and Denmark. Twenty-four blood culture isolates from 22 patients were included in the study, of which 23 isolates were recovered from 21 Thai patients during 2003, 2007, or 2008 and one isolate was recovered from a Danish traveler to Thailand. ESC production was confirmed in 13 out of the 24 isolates by MIC testing. Microarray and plasmid profiling (replicon typing and restriction fragment length polymorphism [RFLP]) were used to characterize the genetic mechanisms of antimicrobial resistance in the 13 ESC-producing isolates. Pulsed-field gel electrophoresis (PFGE) and MIC testing were used to compare the clonality between the 13 ESC-producing isolates and the 11 non-ESC-producing isolates. Based on susceptibility patterns, the ESC-producing isolates were more closely related than non-ESC-producing isolates. Microarray, PCR, plasmid profiling, and replicon typing revealed that the 13 ESC-producing isolates harbored either bla(CMY-2) containing incA/C or bla(CTX-M-14) containing incFIIA, incFrepB, and an unknown replicon located on plasmids ranging in size from 75 to 200 kb. The RFLP and replicon typing clustered the isolates into four distinct groups. PFGE revealed 16 unique patterns and five clusters; each cluster contained two or three of the 24 isolates. The isolate from the Danish patient was indistinguishable from two Thai clinical isolates by PFGE. This study revealed the emergence of the bla(CTX-M-14) gene among several clones of Salmonella serovar Choleraesuis. Numerous plasmids were identified containing up to two different ESC genes and four distinct replicons. A "travel-associated" spread was confirmed. Overall, a high degree of clonal diversity between isolates resistant and susceptible to cephalosporins was observed. The findings represent a serious threat to public health for the Thai people and tourists.

Indexed as

AdolescentAdultAnti-Bacterial AgentsBacteremiaBacterial Typing Techniquesbeta-LactamsBloodCephalosporinaseChildChild, PreschoolCluster AnalysisDenmarkDNA, BacterialDNA FingerprintingFemaleGenotypeAnti-Bacterial Agentsbeta-LactamsCephalosporinaseDNA, Bacterial

Identifiers

PMID20032253
PMCPMC2832443
OpenAlexW2146754832

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.